LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Snibe Demonstrates Cutting-Edge Diagnostic Solutions

By LabMedica International staff writers
Posted on 04 Feb 2025
Image: The space-saving DxC 500i clinical analyzer delivers high-quality chemistry and immunoassay results (Photo courtesy of Snibe)
Image: The space-saving DxC 500i clinical analyzer delivers high-quality chemistry and immunoassay results (Photo courtesy of Snibe)

Snibe (Shenzhen, China) is offering live demonstrations of its cutting-edge diagnostic solutions at Medlab Middle East 2025.

Snibe is highlighting the MAGLUMI X Series CLIA analyzers which is designed to meet the different demands of clinical diagnostics, offering advanced automation, precision, and flexibility. With features like high throughput and seamless integration, it makes a lab's workflow smoother and more efficient. The MAGLUMI X series includes the compact and efficient MAGLUMI X3, designed to maintain high performance within a small footprint. The MAGLUMI X8 features an ultra-high-speed module tailored for high-throughput needs, while the MAGLUMI X6 bridges the gap between the X3 and X8. Each model incorporates Snibe’s revolutionary X-Tech, delivering an exceptional performance experience.

Additionally, Snibe is highlighting the SATLARS-T8, a versatile total laboratory automation solution offering extraordinary efficiency, flexibility, compatibility, and intelligence. It is compatible with Snibe’s extremely high-throughput and multi-discipline laboratory solutions, to meet most clinical testing requirements. Also featured at the event is the powerful and highly flexible SATLARS-TCA Total Laboratory Automation system. Compatible with high-throughput analyzers in multiple disciplines, SATLARS-TCA can minimize the need for manual intervention and greatly improve the testing efficiency of labs. Visitors to the Snibe booth can also experience the Biolumi CX8 integrated system that combines two powerful systems--- Biossays C8 and MAGLUMI X8, to achieve simultaneous biochemical and immunological testing. Moreover, it not only has an ultra-high throughput in a minimal footprint, but can also be customized according to your needs, supporting up to 4 instruments connected, and covering the demands of different laboratories.

 

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more